Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.46 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.46 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.46 |
| ▸ | GALR3 | O60755 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL4230874 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL4002515 | 0.95 | ALDH1A1 (0.56) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL28307391 | 0.95 | ALDH1A1 (0.56) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL24200 | 0.95 | — | — | |
| SCHEMBL11060536 | 0.95 | ALDH1A1 (0.56) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL4412526 | 0.92 | — | — | |
| Acetone SCHEMBL9495889 | 0.92 | ALDH1A1 (0.54) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL5862125 | 0.92 | — | — | |
| SCHEMBL29159554 | 0.92 | — | — | |
| SCHEMBL4406443 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101652712-B | Colored composition and color filter therefrom | TOYO INK MFG CO | 2012-09-05 | — | — | CN | claimed |
| CN-102566278-A | Siloxane polymer composition, cured film and method for forming the cured film | JSR CORP | 2012-07-11 | — | — | CN | claimed |
| WO-2023162519-A1 | PATTERN FORMING METHOD AND METHOD FOR PRODUCING ARTICLE | キヤノン株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023153123-A1 | FILM FORMATION METHOD AND ARTICLE MANUFACTURING METHOD | キヤノン株式会社 | 2023-08-17 | — | — | WO | disclosed |
| EP-4213627-A1 | STABILIZATION OF THIOKETONES ON SURFACES | Bayer Aktiengesellschaft (DE) | 2023-07-26 | — | — | EP | disclosed |
| WO-2023112512-A1 | FILM FORMING METHOD AND METHOD FOR PRODUCING ARTICLE | キヤノン株式会社 | 2023-06-22 | — | — | WO | disclosed |
| WO-2022259748-A1 | CURABLE COMPOSITION, FILM FORMATION METHOD, AND ARTICLE MANUFACTURING METHOD | キヤノン株式会社 | 2022-12-15 | — | — | WO | disclosed |
| US-20220183279-A1 | STABILIZED THIOKETONE FORMULATIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-06-16 | — | — | US | disclosed |
| WO-2022058522-A1 | STABILIZATION OF THIOKETONES ON SURFACES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-03-24 | — | — | WO | disclosed |
| EP-3941199-A1 | STABILIZED THIOKETONE FORMULATIONS | Bayer Aktiengesellschaft (DE) | 2022-01-26 | — | — | EP | disclosed |
| WO-2020187871-A1 | STABILIZED THIOKETONE FORMULATIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-09-24 | — | — | WO | disclosed |
| CN-102375337-A | Photosensitive resin composition | SUMITOMO CHEMICAL CO | 2012-03-14 | — | — | CN | disclosed |
| CN-102375338-A | Coloring composition, method for manufacturing the same, coloring pattern, color filter, color display component and method for manufacturing the color filter | JSR KK | 2012-03-14 | — | — | CN | disclosed |
| CN-102365586-A | Photosensitive coloring composition and color filter | TOYO INK SC HOLDINGS CO LTD | 2012-02-29 | — | — | CN | disclosed |
| CN-102346372-A | Positive photosensitive resin composition and method for forming pattern using the same | CHI MEI CORP | 2012-02-08 | — | — | CN | disclosed |
| EP-2272541-A1 | AROMATIC AGENT COMPOSITION FOR OPENABLE STORAGE SPACE | Kobayashi Pharmaceutical Co., Ltd. (JP) | 2011-01-12 | — | — | EP | disclosed |
| EP-1388756-B1 | Concentrated color developer composition used for silver halide photographic sensitized material and processing method by use thereof | KONISHIROKU PHOTO IND (JP) | 2006-03-08 | — | — | EP | disclosed |
| US-6900004-B2 | Concentrated color developer composition used for silver halide photographic sensitized material and processing method by use thereof | KONICA CORPORATION (JP) | 2005-05-31 | — | — | US | disclosed |
| US-20040067458-A1 | Concentrated color developer composition used for silver halide photographic sensitized material and processing method by use thereof | KONICA CORPORATION (JP) | 2004-04-08 | — | — | US | disclosed |
| EP-1388756-A1 | Concentrated color developer composition used for silver halide photographic sensitized material and processing method by use thereof | KONICA CORPORATION (JP) | 2004-02-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220183279-A1 | STABILIZED THIOKETONE FORMULATIONS | TXK, KHK, PTMA | ALDH1A1 2478/4885TSHR 3354/4885CHRM5 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.